Fas levels in the portal venous blood were significantly higher than those in the peripheral venous blood. These results suggest that in these diseases, activated T cells and soluble molecules in portal venous blood may promote Fas/FasLmediated apoptosis of the bile-duct cells and hepatocytes, and contribute to the deterioration in liver function as an inevitable result of positive feedback.
Introduction
A previous study demonstrated that the gastrointestinal tract of cirrhotic patients showed increased susceptibility to injury induced by several irritants. An impaired hyperaemic response when the epithelium of the mucosal membrane was exposed to these irritants was an important factor in this susceptibility. The impaired response appeared to be related to reduced prostaglandin production and to nitric oxide overproduction in the mucosal layer. Increased production of tumour necrosis factor-α by the gastrointestinal mucosa in portal hypertensive rats has also been shown to have a role in mucosal injury. 1 Biliary atresia (BA), a progressive inflammatory disease and surgical cholestatic disorder in infants, is caused by obstruction of the extrahepatic bile duct; as the intrahepatic bile ducts are also affected, 2,3 hepatic fibrosis leads to liver cirrhosis, and many children with BA need liver transplantation, despite the disappearance of jaundice after successful hepatic portoenterostomy. 2 -4 Patients with end-stage liver cirrhosis due to chronic infection with HCV are indicated for orthotopic liver transplantation worldwide. 5, 6 Failure in remodelling of the ductal plate 7, 8 and perinatal viral infection 9 are considered to be responsible, to some extent, for BA and for cellular immune mechanisms in general. T cells, in particular, are believed to be significantly involved in the pathogenesis of the liver injury in both cholestatic and HCV-positive liver cirrhosis. The detailed pathophysiology of the loss of bile-duct cells and hepatocytes remains unclear, however.
Recent studies demonstrate that apoptosis is involved in bile-duct loss in biliary diseases including BA and primary biliary cirrhosis. 10 -14 The role of apoptosis and apoptosis-related hepatocyte proteins in the livers of patients with HCV-induced chronic hepatitis and liver cirrhosis has been investigated. 15 -20 Both T-cell infiltration and apoptosis have been suggested as mediating the destruction of hepatocytes, and probably the biliary epithelium, in cholestatic liver diseases. 21, 22 Apoptosis is a form of programmed cell death characterized by DNA fragmentation, as a result of activation of endonuclease, and is modulated by several stimulatory and inhibitory proteins such as the direct stimulator of the Fas/FasL pathway. 23 This study aimed to investigate immune responses, in patients with cholestatic and HCV-positive liver cirrhosis, by analysing T-cell subsets and cytokine levels in the portal and peripheral veins, using flow cytometry and enzyme-linked immunosorbent assay (ELISA).
Patients and methods PATIENTS
A total of 20 patients undergoing laparotomy were enrolled in this study. All of the patients (or their parents) gave their informed consent to participate in the study. The patients were all referred to our hospital wards of paediatric surgery, gastroenterological surgery and transplantation for complete diagnostic workups on their untreated liver diseases. The diagnostic work-ups included serological and histological evaluation, as well as conventional criteria such as pathological and laboratory tests, abdominal ultrasonography, computed tomography, magnetic resonance imaging and hepatic angiography. There were four distinct groups of patients (Table 1 ). Patients in the control groups (without cirrhosis) were all negative for hepatitis B surface antigens, anti-hepatitis B core and anti-hepatitis C virus antibodies, and showed normal liver function.
For flow cytometric and ELISA assays 20 ml blood samples were withdrawn from the portal vein and the right atrium, by intravenous and Swan-Ganz catheters, respectively, using evacuated blood collection tubes, immediately after laparotomy. 
FLOW CYTOMETRIC ANALYSIS

IMMUNOHISTOCHEMISTRY
For the immunodetection of FasL by the standard avidin-biotin-peroxidase complex method, 24 formalin-fixed and paraffinembedded sections of the livers of patients with cholestatic or HCV-positive liver cirrhosis were prepared. After deparaffinization and endogenous peroxidase blocking, the sections were incubated with the polyclonal antibody against FasL (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) overnight at 4°C. The sections were then incubated with a biotinylated secondary antibody for 60 min and, after benzidine reaction, were weakly counterstained with haematoxylin.
STATISTICAL ANALYSIS
One-way analysis of variance was applied to mean comparisons and P-values of < 0.05 were considered statistically significant.
Results
In the children, flow-cytometric analysis of T-cell subsets, NK cells (CD3 -CD56 + ) and NK T cells (CD3 + Vα24 + ) in the portal and peripheral venous blood showed that the proportion of NK T cells in portal venous blood was significantly higher than that in peripheral venous blood in those with cirrhosis, whereas the proportions of these T-cell subsets did not differ significantly between portal and peripheral venous blood in those without cirrhosis ( Fig. 1 ). In adults with cirrhosis, the proportions of memory T cells (CD3 + CD45RO + ), Fas + T cells (CD3 + CD95 + , CD4 + CD95 + , CD8 + CD95 + ) and NK T cells in portal venous blood were significantly greater than those in peripheral venous blood, whereas in those without cirrhosis the proportions of T-cell subsets, NK cells and NK T cells did not differ significantly between portal and peripheral venous blood (Fig. 2) .
The serum levels of IL-6 and IL-18 in portal venous blood were found to be significantly higher than those in peripheral venous blood and, in contrast, the serum level of sFasL in peripheral venous blood was significantly higher than that in portal venous blood in children with cirrhosis. In the children without cirrhosis, however, no significant differences in serum levels of IL-6, IL-10, IL-18, sFas and sFasL in portal and peripheral venous blood were seen ( Table 2 ). In the adults the serum levels of IL-6 and sFas in portal venous blood were significantly greater than those in peripheral venous blood in patients with cirrhosis, whereas no significant differences in the levels of soluble factors in portal and peripheral venous blood were seen in those without cirrhosis (Table 2 ).
In both cholestatic and HCV-positive liver cirrhosis the immunohistochemical analysis revealed that FasL was markedly expressed in the cytoplasm of mononuclear cells infiltrated around the bile-duct cells and hepatocytes (Fig. 3 ).
Discussion
Natural-killer T cells, activated by portal hypertensive enteropathy and carried into the liver via the portal vein, appeared to augment the liver injury in patients with cholestatic and HCV-positive liver cirrhosis, since the present study clearly showed that in both children and adults with liver cirrhosis, the proportion of NK T cells in portal venous blood was significantly higher than that in Pathophysiology of cholestatic and HCV-positive liver cirrhosis peripheral venous blood. NK T cells were previously found to be abundant at an intraepithelial site in the intestine, 24 and to play a critical role in the liver injury of Salmonella infection, 25 in mouse Concanvalin A-induced hepatitis, 26 and in human autoimmune diseases such as autoimmune diabetes 27 and systemic sclerosis. 28 Furthermore, these cells exert anti-tumour cytotoxicity and prevent tumour metastasis to the liver or lung. 29 Thus NK T cells are crucial in various immune responses, including anti-tumour immunity, in allergic reactions, and in the development of autoimmune diseases.
Although the precise molecular requirements for the induction of hepatocyte injury are still largely unknown, the significant correlation between apoptosis and hepatic injury has been emphasized over the past few decades. Hepatic injury seems to be induced by several different mechanisms such as those involving Fas/FasL system, 30 -32 perforin/granzyme system 33 and interferon-γ and/or tumour-necrosis-factor-α-mediated cytotoxicity. 34 -40 It is conceivable, however (although there is no direct evidence), that activated T cells in the gut due to portal hypertensive enteropathy are involved in the deterioration of liver function in cholestatic and HCV-positive liver cirrhosis. In the present study in children with liver cirrhosis, the proportion of NK T cells and the proportions of memory T and Fas + T cells in portal venous blood were significantly greater than those in peripheral venous blood, i.e. reflecting portal hypertensive enteropathy (PHE)-induced activation of intestinal T cells. In children and adults without cirrhosis, however, no statistically significant difference was observed between the proportions of activated T-cell subsets The transduction of apoptotic signals by Fas receptors requires ligation by the FasL structure, which is usually expressed on activated T cells. 41 Flow-cytometric analysis in the present study showed that the abundant T cells, supposedly activated in the gut by PHE induction, expressed CD45RO and/or Fas in the portal venous blood of children with cirrhosis. The activated T cells and NK T cells in portal venous blood could also express FasL as well as Fas antigen, and appear to play a roll in the injury of hepatocytes and bile-duct cells expressing Fas, and in deteriorating liver function resulting from positive feedback. The immunohistochemical analysis also confirmed the hypothesis that the cytoplasm of mononuclear cells that infiltrated around the bile-duct cells and hepatocytes, both of which presumably express Fas antigen, showed distinctive FasL expression.
The present findings of high levels of sFas and IL-6 in portal venous blood in adults with cirrhosis indicate that sFas from monocytes/macrophages in the gut may hamper Fas/FasL-mediated death in hepatocytes and bile-duct cells by interfering with FasL ligation. They further indicate that IL-6 from the intestine may be involved in liver regeneration, since Fas/FasL interaction plays a key role in triggering apoptotic cell death. Both Fas and FasL may occur either as membrane-bound or soluble proteins with different functional properties. Moreover, sFas is generated by alternative mRNA splicing, and seems to protect cells from apoptosis, whereas sFasL is produced by proteolytic cleavage of the membrane-bound form and may be pro-apoptotic. 42, 43 High concentrations of sFas and sFasL have been described in lymphocytic disorders. 43 It has recently been reported that plasma concentrations of sFas and sFasL were raised in acute alcoholic hepatitis, 44 which implies a role of the cell-death pathway (sFasL) and of the active antagonistic response (sFas) in these diseases. Furthermore, IL-6 is fundamental for liver regeneration through its anti-inflammatory properties. 45 -47 It has been previously shown that IL-18 can upregulate the functional activity of FasL on Th1 cells and enhanced FasLmediated cytotoxicity. 48 The present study suggests that monocytes/macrophages in the intestine produced IL-18, and that IL-18 production was increased in those with cirrhosis. Portal hypertensive enteropathy may have been ascribable to this since, in children with cirrhosis, the serum levels of IL-18 and IL-6 in portal venous blood were significantly higher than those in peripheral venous blood, and the cytoplasm of Kupffer cells around the bile-duct cells clearly showed FasL expression on immunohistochemical analysis in children with cirrhosis. IL-18 was originally characterized as an interferon-γ-inducing factor in the blood of mice primed with Propionibacterium acnes and stimulated with lipopolysaccharide (LPS); 49 it is secreted by LPS-activated monocytes/macrophages and by a wide variety of cells. 50 -53 In addition, we previously showed that IL-18 released from Kupffer cells could play an important role in the pathophysiology of the progressive inflammation and fibrosis in BA. 54 The serum levels of sFasL in peripheral venous blood was greater than that in portal venous blood in children with cirrhosis. This finding is consistent with the suggestion that could be induced by proteolytic cleavage, and that sFasL might trigger apoptotic cell death in an autocrine or paracrine fashion. Since the membrane-bound FasL is converted to a soluble form by matrix metalloproteinasedriven cleavage, 42, 43 the balance between the tissue distribution of metalloproteinases and their tissue inhibitor may be important in the increased sFasL level.
In conclusion, we suggest that the imbalance of cellular degrading and proliferating fractions of bile-duct cells and hepatocytes could induce progressive loss of bile-duct cells and hepatocytes, mainly caused by enhanced Fas/FasL-mediated apoptosis, in cholestatic and HCV-positive liver cirrhosis patients at the stage of portal hypertensive enteropathy. The present results indicate that in cholestatic liver cirrhosis, the increased NK T cells and elevated IL-18 levels in portal venous blood, due to portal hypertensive enteropathy, play a role in accelerating Fas/FasL-mediated apoptosis of bile-duct cells, leading to the disappearance of the bile duct. They further suggest that, in HCV-positive liver cirrhosis, the increased NK T cells and activated T cells in the portal venous blood are involved in promoting the death of hepatocytes by means of the Fas/FasL system. In addition, the serum levels of IL-6 in the portal vein in patients with cholestatic liver cirrhosis were significantly increased, as were levels of IL-6 and sFas in HCV-positive liver cirrhosis (both of which appeared to have roles in liver regeneration and/or protection against apoptotic cell death). Further studies are needed to provide more clarification. 
